Printer Friendly

THE BREAST IMPLANT CONTROVERSY: WOMEN WITH THE MOST AT STAKE

 THE BREAST IMPLANT CONTROVERSY: WOMEN WITH THE MOST AT STAKE
 Coloplast Inc. today released the following backgrounder:
 The breast implant controversy has overlooked thousands of women who have the most at stake in this heated debate; women who have had mastectomies but don't want implants or other breast reconstruction. The Food and Drug Administration estimates that 200,000 women have had breast implants to replace breasts lost by cancer. These women only had two choices: surgical reconstruction or an external breast prosthesis.
 External breast forms have been the overwhelmingly popular choice for women who have had a mastectomy. Nearly 2 million women have opted for a breast form instead of breast reconstruction. Breast forms effectively help a woman achieve the natural look she desires and do not involve invasive surgery.
 Recently, significant advances have made breast forms more acceptable and physically pleasing for women who've had a mastectomy. For example, Coloplast Inc. has developed Discrene, a revolutionary new external breast form that adheres to a woman's chest wall through the use of skin-friendly materials and velcro-like attachments. Unlike traditional forms, Discrene doesn't need a special bra to be held in place and enables a woman to go braless, swim and wear sexy lingerie. Women who've worn Discrene say it weighs, feels and moves just like a natural breast.
 When recovering from a mastectomy, many women go directly to a fitter to find a prosthesis. Johanna Ehmann, RN, an oncology nurse, states, "Women recovering from a mastectomy need positive reinforcement when making the decision to be fitted for a breast form or undergo breast reconstruction. A woman must be happy with her new image and should explore her options fully."
 For more information about post-mastectomy options or an interview with Ehmann, call contact below.
 CONTACT: Lucia Aurello or Laurie McGrane, 212-684-6300, for Coloplast.
 -0- 3/26/92


CO: Coloplast Inc. ST: IN: SU: PDT

SH-GK -- NY076 -- 2085 03/26/92 15:36 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 26, 1992
Words:322
Previous Article:EPA ORDERS POTENTIALLY RESPONSIBLE PARTIES TO DESIGN AND IMPLEMENT CLEANUP OF SUPERFUND SITE IN BROOKS, KY.
Next Article:COURIER SIGNALS SECOND QUARTER LOSS
Topics:


Related Articles
SILICONE BREAST IMPLANTS: THE FDA BANS THEIR USE. NOW WHAT?
MENTOR CORP. OFFERS SALINE-FILLED BREAST IMPLANTS AS ALTERNATIVE TO SILICONE
MENTOR CORP. OFFERS SALINE-FILLED BREAST IMPLANTS AS ALTERNATIVE TO SILICONE
MT. SINAI DOCTOR RESPONDS TO RECENT BREAST IMPLANT CONTROVERSY
AESTHETIC PLASTIC SURGEONS SAY FDA PANEL RECOMMENDATIONS WILL LEAVE WOMEN CONFUSED AND CONCERNED
Breast implants, Hippocrates, and burden of proof.
WOMEN'S IMPLANT INFORMATION NETWORKHAILS LIFTING OF FRENCH MORATORIUM ON SILICONE GEL IMPLANTS
Dow Corning Files Motion to Resolve Implant Claims
Saline Breast Implants.
FDA Hearings on Silicone Breast Implants; ANALYSIS of FDA & INDUSTRY DATA.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters